Company Filing History:
Years Active: 2022
Title: Kensei Yamaguchi: Innovator in Cancer Research
Introduction
Kensei Yamaguchi is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of cancer research, particularly in the development of biomarkers for predicting therapeutic effects of antibody drugs.
Latest Patents
Kensei Yamaguchi holds a patent for "Biomarkers, test method, and test kit for predicting therapeutic effect of anti-VEGFR-2 antibody drug." This patent focuses on predicting the therapeutic effect and prognosis after administering an anti-VEGFR-2 antibody drug, specifically ramucirumab. The prediction is achieved by measuring various biomarkers, including VEGF-A, VEGF-D, sVEGFR-2, SDF-1α, and cNRP1. This innovation provides a valuable tool for assessing the effectiveness of cancer treatments.
Career Highlights
Yamaguchi is affiliated with the Japanese Foundation for Cancer Research, where he continues to advance his work in cancer therapeutics. His research has the potential to improve patient outcomes by enabling more personalized treatment strategies.
Collaborations
Kensei Yamaguchi collaborates with notable colleagues, including Tetsuo Mashima and Takeru Wakatsuki. Their combined expertise enhances the research efforts at the Japanese Foundation for Cancer Research.
Conclusion
Kensei Yamaguchi's work exemplifies the critical role of innovation in cancer treatment. His contributions through patents and research are paving the way for more effective therapies in the fight against cancer.